Certain HIV Meds Linked to Reduced Alzheimer’s Risk
The use of nucleoside reverse transcriptase inhibitors, but not other HIV medicines, is linked to a reduced risk for Alzheimer’s disease, new research shows.
Related Articles
The Role of Obesity in Heart Health
Here’s how to coach your patients with obesity to healthier hearts.
Medicare Advantage Plans: Where’s the Advantage?
Many Medicare Advantage plans are not delivering better, more efficient care than traditional Medicare, and they need more oversight and accountability, Madelaine A. Feldman, MD,…
Medscape
Transforming Gastric and GEJ Cancer Care With Perioperative Immunotherapy: Latest Updates From Chicago
New Guidelines Aim to Make Psychedelic Trials Safer, Clearer, and FDA-Ready
An international expert panel has developed the first consensus-based framework for reporting ‘set and setting’ variables in psychedelic clinical trials.
Las Vegas Dermatology Seminar
Join us in for the 26th annual Las Vegas Dermatology seminar for the latest advancements in psoriasis, acne management and treatment, rosacea, cutaneous malignancies, and…
Cashew Emerges as Leading Cause of Tree Nut-Induced Anaphylaxis in Children
A study using data from a European registry shows cashew as the most frequent elicitor of tree nut-induced anaphylaxis in children.
Calculator Predicts Antihistamine Response in Urticaria
Understanding which patients are less likely to respond to first-line therapy may help clinicians arrive at an effective treatment sooner.
Cannabis Hard on the Heart and Doubles Risk for CVD Death, Major Study Shows
Cannabis users have significantly higher risks for dying from cardiovascular disease, according to a sweeping new study, prompting experts to call for tobacco-style regulation.
Day in the Life: Clinical Trialist Drives Next-Gen AML Care
Naval Daver, MD, a hematologist-oncologist who has led more than 100 clinical trials, predicts the next 5 years will see successful development of cellular therapies…
Skills Lab: Understanding Misconceptions About PFS in Cancer Care
Dr Bishal Gyawali discusses how physicians and patients understand surrogate endpoints, and whether appropriate clinical decisions are made on the basis of this understanding.
